CAR-Immunotherapy PUBLISHED RESULTS

The CAR-Immunotherapy results file contains 12 categories of information for 69 full papers and 22 case reports that were published through 31 July 2018. The latest release is color-coded so that papers published since our last release through Dec. 2017 are highlighted green. Purchasers will receive FREE UPDATES twice a year for the next 3 years.

For each publication, the following topics are covered:

  1. Trial ID
  2. Publication ID and link
  3. First/ last author and year of report
  4. Conditions
  5. CAR target
  6. Trial endpoints
  7. Number of patients (enrolled, infused, evaluable)
  8. Safety/ adverse events data
  9. Efficacy data
  10. CAR cells persistence in vivo
  11. Durability of response
  12. Were endpoints met?

Release 4 covers publications up to 31 July 2018, including 9 full papers published in the first half of 2018.

  • 2 trial results were updated for liquid malignancies with data from the most recent publications (2018)
  • 4 more trials and 5 new full papers (one trial was not registered) were added to liquid malignancies
  • 2 more trials and 2 new full papers were added to solid malignancies
  • 4 more clinical case reports added (second tab)
  • changes from the previous update are highlighted in green

CellTrials.org CAR-Immunotherapy trials verus publications

Public samples: